In the field of medicine, women have historically been overlooked, leading to significant disparities in healthcare and medical research. Despite accounting for over half of the healthcare workforce, women often face biases that undermine their contributions and expertise. These biases can manifest in various forms, from subtle discrimination to outright exclusion from decision-making processes and leadership roles.
I want to start off this blog by talking about the current gender pay gap. In Canada, male doctors earn around 10% more than female doctors. This is due to a few factors. Mainly, women doctors get less referrals than male doctors. They are also often told to do less intense procedures. The good thing is, there are a lot of associations in Canada that are trying to fix this pay gap, and pay their women properly.
Women are constantly overlooked and undermined in healthcare. There are a lot of reasons for this. Throughout history, women were not considered to have normal bodies even though they account for half of the population. Male bodies were considered normal, so medical researchers only studied male anatomy. Many researchers even completely avoided studying on female mice, because they cost more. However, women's anatomy is extremely different from men, meaning they will experience health issues differently. Since women are so under researched, females are far more affected by every day medications. Studies show that women experience side effects from medications at twice the rate of men.
Historically, physicians have viewed women's bodies as abnormal and men's bodies as the standard, even though women make up close to half of the world's population. Despite policy and societal changes in the 1990s contributing to progress, women continue to be significantly underrepresented in research. Numerous medical researchers often refrain from studying female mice due to higher expenses related to acquiring and caring for both genders and worries that the variable hormones and reproductive cycles of female mice could skew the findings. This leads to health care inequalities, as biological sex can impact physiological, metabolic, hormonal, and even cellular variances that affect disease manifestations and the efficacy of medications and medical technologies. Neglecting to research medications and other treatments in a diverse group of women has led to women facing negative effects from medications at twice the rate of men. A 2013 study revealed that women with metal hip replacements had a 29% higher likelihood than men of experiencing implant failure, potentially due to anatomical variations and insufficient testing on women. Although heart disease is the top cause of death in the United States for both genders, the medical community only acknowledged that women display distinct symptoms of the illness compared to men when the American Heart Association released a Guide to Preventive Cardiology for Women in 1999. Separate from biological sex differences, women also are less likely to receive appropriate prevention and management of heart disease due to gender bias.
In conclusion, the persistent gender biases in the medical field not only undermine the contributions of women but also lead to significant health disparities, as evidenced by the lack of research on female anatomy and the resulting negative effects on women's health outcomes. Addressing these inequalities is crucial for ensuring that healthcare is equitable and effective for all, highlighting the urgent need for continued advocacy and reform in medical research and practice.
Create Your Own Website With Webador